The Australian Competition and Consumer Commission is alleging bid rigging by six companies and five individuals, including Moses and Paul Obeid, sons of disgraced former state Labor minister Eddie Obeid.
The Federal Court proceedings relate to the Mount Penny coal exploration licence, which was examined in detail by ICAC in 2013.
The Obeid family owned land in the Bylong Valley, located in the state’s Hunter region, covered by the coal exploration licence.
The ACCC is alleging that a company called Loyal Coal, associated with Paul and Moses Obeid, agreed to withdraw from the NSW Government’s tender process for a mining exploration licence in return for a 25 per cent stake in the project and the purchase of the land for four times its value.The ACCC said Cascade won the tender after Loyal withdrew its bid.
ACCC chairman Rod Sims said a company related to Loyal, which held the 25 per cent interest in the project, later sold that for benefits valued at $60 million, of which around $30 million was cash distributed to beneficiaries of an Obeid family trust.
“The Obeid family interests were involved in this, we allege — the $30 million that was part of the settlement for buying back 25 per cent interest in Cascade,” Mr Sims told The World Today.
“That cash went to a range of Obeid family interests … but the two people most closely involved, we allege, are Moses and Paul Obeid.”
The ACCC said the alleged agreement cost NSW taxpayers millions in lost fees.
Full content: Business Insider
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas